Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jan 28 2016

Full Issue

Manchin Places Hold On Obama's FDA Nominee

The West Virginia senator, who is concerned about Robert Califf's ties to the pharmaceutical industry, is the latest in a string of senators to block the nominee. However, the administration says it has "full confidence" he will get approved.

The Associated Press: Sen. Manchin Joins Growing Opposition To FDA Nominee

Add West Virginia Sen. Joe Manchin to the growing list of lawmakers vowing to block President Barack Obama's nominee to head the Food and Drug Administration. In a statement Wednesday, Manchin cited Dr. Robert Califf's ties to the pharmaceutical industry and argued that it would make it difficult for him to deal with the prescription opioid crisis. Califf was a cardiologist and medical researcher at Duke University for more than 30 years. (1/27)

The Wall Street Journal: White House Remains Confident In FDA Nominee

The Obama administration has “full confidence” in its nominee to run the Food and Drug Administration despite a Democratic senator’s plan to filibuster the nomination, White House press secretary Josh Earnest said Wednesday. Mr. Earnest said the White House is confident Robert Califf has the ability “to make the kinds of decisions that are in the best interests of the health and safety of the American people.” (Burton, 1/27)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF